Remed Co.,Ltd. (KOSDAQ: 302550)
South Korea
· Delayed Price · Currency is KRW 3,790.00
-10.00 (-0.26%)
Dec 20, 2024, 9:00 AM KST
Remed Co.,Ltd. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Operating Revenue | 23,423 | 18,536 | 21,363 | 20,195 | 16,633 | 18,550 |
| Other Revenue | - | - | - | -0 | - | - |
| Revenue | 23,423 | 18,536 | 21,363 | 20,195 | 16,633 | 18,550 |
| Revenue Growth (YoY) | 20.67% | -13.23% | 5.79% | 21.42% | -10.34% | - |
| Cost of Revenue | 11,079 | 9,589 | 10,293 | 9,880 | 8,057 | 7,930 |
| Gross Profit | 12,344 | 8,947 | 11,071 | 10,315 | 8,576 | 10,620 |
| Selling, General & Admin | 7,692 | 7,949 | 6,593 | 5,711 | 4,243 | 3,809 |
| Research & Development | 3,132 | 2,940 | 2,426 | 2,731 | 2,288 | 2,137 |
| Other Operating Expenses | 91.54 | 97.1 | 88.47 | 53.18 | 143.28 | 120.05 |
| Operating Expenses | 11,891 | 11,807 | 9,410 | 9,192 | 6,892 | 6,333 |
| Operating Income | 453.3 | -2,860 | 1,661 | 1,123 | 1,684 | 4,288 |
| Interest Expense | -1,119 | -1,244 | -966.8 | -775.51 | -416.03 | -147.44 |
| Interest & Investment Income | 405.44 | 847.53 | 687.73 | 706.26 | 232.96 | 67.91 |
| Earnings From Equity Investments | -166.42 | -150.16 | -111.99 | -100.22 | -90.73 | - |
| Currency Exchange Gain (Loss) | -88.84 | 334.91 | 272.88 | 542.56 | -701.49 | -76.83 |
| Other Non Operating Income (Expenses) | -193.98 | -283.26 | 3,424 | -576.44 | -3,000 | 318.68 |
| EBT Excluding Unusual Items | -709.54 | -3,355 | 4,967 | 919.81 | -2,291 | 4,450 |
| Gain (Loss) on Sale of Investments | -22.79 | 342.47 | -336.6 | - | - | 143.36 |
| Gain (Loss) on Sale of Assets | 4,400 | -0.01 | -70.63 | -36.72 | 11.92 | -27.34 |
| Other Unusual Items | 1,385 | 3,992 | - | - | - | 22.73 |
| Pretax Income | 5,052 | 979.66 | 4,560 | 883.08 | -2,279 | 4,589 |
| Income Tax Expense | 682.57 | 660.41 | 608.71 | 130.75 | -445.46 | 225.47 |
| Earnings From Continuing Operations | 4,369 | 319.24 | 3,951 | 752.33 | -1,834 | 4,363 |
| Minority Interest in Earnings | 493.96 | 477.92 | 48.88 | - | - | - |
| Net Income | 4,863 | 797.17 | 4,000 | 752.33 | -1,834 | 4,363 |
| Net Income to Common | 4,863 | 797.17 | 4,000 | 752.33 | -1,834 | 4,363 |
| Net Income Growth | - | -80.07% | 431.70% | - | - | - |
| Shares Outstanding (Basic) | 31 | 31 | 31 | 31 | 30 | 26 |
| Shares Outstanding (Diluted) | 31 | 31 | 31 | 31 | 30 | 26 |
| Shares Change (YoY) | 1.65% | - | 0.35% | 1.84% | 14.35% | - |
| EPS (Basic) | 158.73 | 26.02 | 130.56 | 24.64 | -61.17 | 166.43 |
| EPS (Diluted) | 158.73 | 26.00 | 130.56 | 24.60 | -61.20 | 166.40 |
| EPS Growth | - | -80.09% | 430.73% | - | - | - |
| Free Cash Flow | 5,823 | 2,708 | 261.1 | -7,431 | 1,911 | 1,213 |
| Free Cash Flow Per Share | 190.05 | 88.40 | 8.52 | -243.41 | 63.75 | 46.26 |
| Gross Margin | 52.70% | 48.27% | 51.82% | 51.08% | 51.56% | 57.25% |
| Operating Margin | 1.94% | -15.43% | 7.78% | 5.56% | 10.12% | 23.11% |
| Profit Margin | 20.76% | 4.30% | 18.72% | 3.73% | -11.02% | 23.52% |
| Free Cash Flow Margin | 24.86% | 14.61% | 1.22% | -36.80% | 11.49% | 6.54% |
| EBITDA | 1,675 | -1,905 | 2,417 | 1,684 | 2,079 | 4,675 |
| EBITDA Margin | 7.15% | -10.28% | 11.31% | 8.34% | 12.50% | 25.20% |
| D&A For EBITDA | 1,222 | 954.51 | 755.6 | 560.7 | 395.47 | 387.05 |
| EBIT | 453.3 | -2,860 | 1,661 | 1,123 | 1,684 | 4,288 |
| EBIT Margin | 1.94% | -15.43% | 7.78% | 5.56% | 10.12% | 23.11% |
| Effective Tax Rate | 13.51% | 67.41% | 13.35% | 14.81% | - | 4.91% |
| Advertising Expenses | - | 725.79 | 420.15 | 299.26 | 70.05 | 259.34 |
Source: S&P Capital IQ. Standard template. Financial Sources.